United Kingdom News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on United Kingdom News Watch.

Press releases published on October 1, 2026

Oct. 1, 2026

Un informe de Templafy revela que el 95% de los trabajadores del conocimiento edita los documentos generados por IA antes de que estén listos para uso empresarial

Indeterminate GlobeNewswire

Oct. 1, 2026

Une étude de Templafy révèle que 95 % des travailleurs du savoir retouchent les documents générés par l’IA avant de pouvoir les utiliser

Indeterminate GlobeNewswire

Oct. 1, 2026

דו"ח של Templafy מצא ש-95% מעובדי הידע עורכים מסמכים שנוצרו בידי בינה מלאכותית לפני שהם מוכנים לשימוש עסקי

Indeterminate GlobeNewswire

Oct. 1, 2026

Laporan Templafy Mengungkap 95% Pekerja Intelektual Mengedit Dokumen Buatan AI Sebelum Siap Digunakan untuk Kebutuhan Bisnis

Indeterminate GlobeNewswire

Oct. 1, 2026

テンプラファイのレポートで、ナレッジワーカーの95%が、AIが生成した文書を、実務で使用できる状態にするために修正していることが判明

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy 보고서 “지식근로자 95%, AI 생성 문서를 실제 업무 활용 전에는 수정”

Indeterminate GlobeNewswire

Oct. 1, 2026

Laporan Templafy Mendapati 95% Pekerja Berpengetahuan Menyunting Dokumen yang Dijana AI Sebelum Dokumen Tersebut Sedia Digunakan dalam Perniagaan

Indeterminate GlobeNewswire

Oct. 1, 2026

Relatório da Templafy Revela que 95% dos Profissionais do Conhecimento Editam Documentos Gerados por IA Antes do Uso nos Negócios

Indeterminate GlobeNewswire

Oct. 1, 2026

รายงานจาก Templafy ชี้แรงงานสายความรู้ 95% ต้องแก้ไขเอกสารที่จัดทำโดย AI…

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy 报告发现：95% 的知识工作者在 AI 生成文档达到商用标准前仍需手动编辑

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy 報告發現，95% 的知識工作者在 AI 生成文件準備好用於業務前會先行編輯

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy Report Finds 95% of Knowledge Workers Edit AI-Generated Documents Before They’re Business-Ready

Indeterminate GlobeNewswire

Oct. 1, 2026

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

Nxera Announces Successful Resolution of miniG Patent Infringement Action

Indeterminate GlobeNewswire

Oct. 1, 2026

DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform

Indeterminate GlobeNewswire

Oct. 1, 2026

Total Voting Rights

Indeterminate GlobeNewswire

Oct. 1, 2026

EMGA's continued success in Brazil

Indeterminate GlobeNewswire

Oct. 1, 2026

Mironid successfully doses initial cohorts in Phase 1 clinical trial investigating the Company’s first-in-class LoAc® small molecule for patients with ADPKD

Indeterminate GlobeNewswire